Industry
Isle of Man pharmacies to trial dispensing medical cannabis products
Patients may soon be able to access their prescriptions through a local pharmacy.
Medical cannabis patients on the Isle of Man may soon be able to access their prescriptions through a local pharmacy, under a new Government pilot scheme.
The Department of Health and Social Care is looking to partner with an on-island community pharmacy, to trial an import and dispensing service for Cannabis Based Medicinal Products (CBMP).
This means that patients with private prescriptions for medicinal cannabis products will be able to access products on the island, through a “quality assured and accredited dispensary process”.
A public consultation in 2019 showed overwhelming support for providing a route through which patients could obtain cannabis based medicinal products on prescription.
But currently patients who hold prescriptions on the Isle of Man are required to import their medication, which is distributed by cannabis dispensaries in the UK.
The Government now is seeking an on island pharmacy based service to operate the scheme as a pilot for a minimum of 12 months, as the “next stage in the journey” of enabling patients to access these medicines.
According to an official release from the Department of Health, alongside the importation and dispensing of products, the pharmacy will play a key role in developing a robust governance process and in helping collect data and evidence of current needs to shape future services.
Read more: Proposal for medical cannabis facility put forward on Isle of Man
A statement on the Government website said: “Isle of Man residents seeking medical cannabis will need to do so via a private prescription from a private clinic in the United Kingdom or Crown Dependencies, by clinicians who are on the Specialist Register of the General Medical Council (GMC) and who can prescribe such products.
“At this time prescriptions for any CBMP will not be available on the NHS from the Department or Manx Care, as the NHS on the Island does not routinely fund non-NICE approved treatments. Residents will be personally responsible for paying for these private prescriptions.”
Any pharmacy interested in providing this local service is invited to respond through the online procurement portal. Full details of the requirements and expectations can be found here .
The closing date for applications is 20 April, 2022.
-
News4 months agoLuxembourg to Restrict Access to Medical Cannabis Flower on Prescription
-
News5 months agoNHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access
-
Epilepsy5 months agoUCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For
-
News6 months agoSpain’s proposed medical cannabis framework too ‘restrictive’, say patients
-
Health3 months agoUK IBD Patients Report Improvements With Medical Cannabis
-
News4 months agoGPs in Czech Republic Permitted To Prescribe Medical Cannabis From 2025
-
News4 weeks agoClosing the Gap: How Real-World Evidence Could Reshape UK Medical Cannabis Policy
-
Health4 months agoCBD Shows Promise in Treatment of Endometriosis, Say Leading Women’s Health Researchers
